живот аргумент постоянно nature medicine crispr екскременти йерархия Очаквано
Kill Switch for CRISPR Could Make Gene Editing Safer - Scientific American
New CRISPR genome-editing system can target disease-causing genetic variations – Harvard Gazette
Untangling the CRISPR cancer scare
A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers
CRISPR gene editing - Wikipedia
CRISPR, the disruptor : Nature News & Comment
Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
CRISPR: gene editing is just the beginning : Nature News & Comment
CRISPR-Cas 9 corrects genetic defects in mice
Focus on CRISPR tools and therapies | Nature Biotechnology
Is Crispr the Next Antibiotic? - The New York Times
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
First CRISPR editing trial results assuage safety concerns
CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review
CRISPR algorithm predicts how well gene editing will work - Scope
Nature Medicine on Twitter: "Two studies find that #AAV-mediated #CRISPR/ Cas9 therapy extends life span and ameliorates disease-related phenotypes in a mouse model of #progeria. https://t.co/2LfOogSXLX and https://t.co/y5KjuD5Yjb… https://t.co/RMaa25wQoI"
CRISPR-Cas9 babies likely to die earlier, Berkeley study says | Science| In-depth reporting on science and technology | DW | 03.06.2019
Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
PDF) The CRISPR tool kit for genome editing and beyond
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL